Related Experiment Videos
Urinary excretion of prostaglandins and electrolytes in developing children
Insights
Urinary prostaglandin (PG) E and Falpha excretion increases with age in children, correlating with potassium levels. These findings suggest renal PGs are vital for regulating kidney potassium excretion.
Area of Science:
- Pediatric Nephrology
- Biochemistry
Background:
- Prostaglandins (PGs) are crucial signaling molecules involved in various physiological processes.
- Understanding prostaglandin dynamics in children is essential for diagnosing and managing kidney disorders.
Purpose of the Study:
- To investigate the longitudinal changes in urinary prostaglandin E (PGE) and Falpha (PGFalpha) excretion in healthy children.
- To explore the relationship between urinary PGs, electrolytes, and osmolality in children.
- To examine the role of PGs in Bartter's syndrome.
Main Methods:
- Longitudinal study of urinary PGE and PGFalpha excretion in 55 healthy children (1-114 months).
- Analysis of urinary PGs and electrolytes in 6 children with Bartter's syndrome before and after indomethacin treatment.
- Statistical correlation analysis between PG excretion, age, urinary osmolality, and electrolytes (potassium, sodium).
Main Results:
- Urinary PGE and PGFalpha excretion increased with age in healthy children, particularly before 24 months.
- Significant positive correlations were observed between urinary PGs and osmolality in younger children.
- Urinary PG excretion correlated significantly with potassium excretion but not sodium excretion in all children.
- Children with Bartter's syndrome showed increased urinary PGE, PGFalpha, and potassium excretion post-treatment.
Conclusions:
- Renal prostaglandins (PGs) may play a significant role in regulating potassium excretion in the kidneys.
- Establishing age-specific reference ranges for urinary PG excretion is necessary for accurate clinical interpretation.
- The study highlights the involvement of PGs in the pathophysiology of Bartter's syndrome.
Abstract:
A longitudinal study of the urinary excretion of prostaglandins (PG's) E and Falpha was performed in 55 healthy children aged from 1 to 114 months. In addition, the urinary PG's and electrolytes were studied in 6 children with Bartter's syndrome before and after an oral treatment with indomethacin. In normal children, both urinary PGE and PGF alpha increased with age, more markedly before 24 months of age. During this period, a positive and significant correlation was found with the urinary osmolality (r = 0.61, N = 16, P less than 0.05 for PGE; r = 0.82, N = 16, P less than 0.001 for PGF alpha). At every age, the urinary PG's were related to the potassium excretion (r = 0.68, N = 55, P less than 0.001 for PGE; r = 0.65, N = 55, P less than 0.002 for PGFalpha) but not to the natriuresis. In children with Bartter's syndrome, the increased urinary excretion of PGE, PGFalpha and potassium when the natriuresis was either decreased or increased after treatment. These results suggest that the renal PG's might play a role in the control of potassium excretion by the kidney. In addition, the determination of normal values in different age groups appears necessary for an accurate interpretation of the urinary PG's.